Results 281 to 290 of about 445,623 (380)

Lymphocyte Involvement in the Pathology of Pulmonary Arterial Hypertension. [PDF]

Int J Mol Sci
Tomaszewski M, Styczeń A, Krysa M, Michalski A, Morawska-Michalska I, Hymos A, Wawer J, Rolińska A, Rahnama M, Urbanowicz T, Grywalska E.   +10 more
europepmc   +1 more source

Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantation

ESC Heart Failure, EarlyView.
Abbreviations: TAVI, transcatheter aortic valve implantation; ATTR‐CM, transthyretin cardiac amyloidosis. We aimed to diagnose occult ATTR‐CM in patients with severe aortic stenosis undergoing TAVI using bone scintigraphy. We verified a diagnosis of ATTR‐CM in 8 of 171 (4.7 %) consecutive aortic stenosis patients who underwent TAVI.
Margrethe Flesvig Holt, August Flø, Esra Kaya, Sophie Foss Kløve, Hege Martinsen, Kristine Amlie, Petter Storsten, Thomas Misje Mathiisen, Kristoffer Russell, Christian Hesbø Eek, Helge Skulstad, Melinda Raki, Lars Gullestad, Anders Hodt, Einar Gude, Kaspar Broch   +15 more
wiley   +1 more source

RPL39 Was Associated With Sex Differences in Pulmonary Arterial Hypertension. [PDF]

Can Respir J
Wang H, Li L, Zhou G, Wang L, Wu Z.
europepmc   +1 more source

Microaxial pump‐supported coronary surgery without CPB to optimize outcome in severely impaired left ventricles

ESC Heart Failure, EarlyView.
Abstract Aims Cardiopulmonary bypass (CPB) is the standard approach for coronary artery bypass grafting (CABG) in advanced ischaemic cardiomyopathy. Microaxial pump support has been envisioned to allow for beating‐heart CABG without CPB (MPCAB), thereby avoiding CPB‐inherent complications.
Anna Kathrin Assmann, Merve Arik‐Doganay, Sebastian Waßenberg, Payam Akhyari, Artur Lichtenberg, Alexander Assmann   +5 more
wiley   +1 more source

858-3 Subcutaneous treprostinil therapy evokes both survival benefit and continuous dose-dependent efficacy improvements in patients with pulmonary arterial hypertension: A long-term European multicentre analysis of 112 patients

, 2004
Iréne Lang, Miguel Ángel Gómez‐Sánchez, Meinhard Kneußl, Pilar Escribano Subías, Robert Naejie, Jean-Luc Vachiéry   +5 more
openalex   +1 more source

Pulmonary Arterial Hypertension in a Patient With a Lung Mass: Any Link? [PDF]

Cureus
Alharbi AM, Alqarni MS, Alkahtani AA, Alghamdi B.   +3 more
europepmc   +1 more source

Survival after myocardial infarction according to left ventricular function and heart failure symptoms

ESC Heart Failure, EarlyView.
Asymptomatic reduced left ventricular ejection fraction (LVEF) in the acute phase of myocardial infarction (AMI) was associated with up to 20% 1‐year mortality after discharge, substantially higher than in recent post‐MI trials. Symptoms of heart failure (HF) during the index hospitalization was associated with worse outcomes in patients with preserved
Jarle Jortveit, Peder L. Myhre, Kristian Berge, Sigrun Halvorsen   +3 more
wiley   +1 more source

Multi-kingdom gut microbiota dysbiosis is associated with the development of pulmonary arterial hypertension. [PDF]

EBioMedicine
Chen Y, Chen Z, Liang L, Li J, Meng L, Yuan W, Xie B, Zhang X, Feng L, Jia Y, Fu Z, Su P, Tong Z, Zhong J, Liu X.   +14 more
europepmc   +1 more source

A multicentre registry of hospitalized patients with acute and chronic heart failure: Study design of the H2‐registry

ESC Heart Failure, EarlyView.
The H2‐Registry: overview, first results and outlook. Abstract Aims Heart failure (HF) is a highly prevalent condition affecting 1–3% of the adult population in Europe. Despite landmark improvements in HF care over the last two decades, hospitalization and mortality rates remain relatively high.
Johannes Leiner, Sebastian König, Anne Nitsche, Sven Hohenstein, Jana Nagel, Melchior Seyfarth, Henning Baberg, Alexander Lauten, Hans Neuser, Alexander Staudt, Jürgen Tebbenjohanns, René Andrié, Michael Niehaus, Markus W. Ferrari, Ralf Kuhlen, Andreas Bollmann   +15 more
wiley   +1 more source